Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MARKSANS PHARMA. vs WOCKHARDT - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MARKSANS PHARMA. WOCKHARDT MARKSANS PHARMA./
WOCKHARDT
 
P/E (TTM) x 21.5 -15.8 - View Chart
P/BV x 3.9 2.5 156.2% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 MARKSANS PHARMA.   WOCKHARDT
EQUITY SHARE DATA
    MARKSANS PHARMA.
Mar-23
WOCKHARDT
Mar-23
MARKSANS PHARMA./
WOCKHARDT
5-Yr Chart
Click to enlarge
High Rs74316 23.6%   
Low Rs39145 26.6%   
Sales per share (Unadj.) Rs40.9184.0 22.2%  
Earnings per share (Unadj.) Rs5.9-43.1 -13.6%  
Cash flow per share (Unadj.) Rs7.0-25.7 -27.3%  
Dividends per share (Unadj.) Rs0.500-  
Avg Dividend yield %0.90-  
Book value per share (Unadj.) Rs38.5231.7 16.6%  
Shares outstanding (eoy) m453.16144.09 314.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.41.3 110.5%   
Avg P/E ratio x9.7-5.3 -180.7%  
P/CF ratio (eoy) x8.1-9.0 -90.1%  
Price / Book Value ratio x1.51.0 147.7%  
Dividend payout %8.50-   
Avg Mkt Cap Rs m25,63133,202 77.2%   
No. of employees `000NANA-   
Total wages/salary Rs m2,3946,370 37.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m18,52126,510 69.9%  
Other income Rs m5931,220 48.6%   
Total revenues Rs m19,11527,730 68.9%   
Gross profit Rs m3,393-1,930 -175.8%  
Depreciation Rs m5192,510 20.7%   
Interest Rs m913,020 3.0%   
Profit before tax Rs m3,377-6,240 -54.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m723-30 -2,411.1%   
Profit after tax Rs m2,653-6,210 -42.7%  
Gross profit margin %18.3-7.3 -251.6%  
Effective tax rate %21.40.5 4,455.8%   
Net profit margin %14.3-23.4 -61.2%  
BALANCE SHEET DATA
Current assets Rs m16,99719,140 88.8%   
Current liabilities Rs m3,65434,350 10.6%   
Net working cap to sales %72.0-57.4 -125.6%  
Current ratio x4.70.6 834.9%  
Inventory Days Days639 14.5%  
Debtors Days Days8211 748.6%  
Net fixed assets Rs m5,24648,670 10.8%   
Share capital Rs m453720 62.9%   
"Free" reserves Rs m16,99832,660 52.0%   
Net worth Rs m17,45233,380 52.3%   
Long term debt Rs m02,240 0.0%   
Total assets Rs m22,24270,750 31.4%  
Interest coverage x38.0-1.1 -3,563.1%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.80.4 222.2%   
Return on assets %12.3-4.5 -273.7%  
Return on equity %15.2-18.6 -81.7%  
Return on capital %19.9-9.0 -219.8%  
Exports to sales %00-   
Imports to sales %7.33.5 209.8%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m1,348920 146.6%   
Fx inflow Rs m6,491730 889.2%   
Fx outflow Rs m1,348920 146.6%   
Net fx Rs m5,143-190 -2,706.9%   
CASH FLOW
From Operations Rs m2,3741,530 155.2%  
From Investments Rs m-2,592-1,250 207.4%  
From Financial Activity Rs m1,978-3,150 -62.8%  
Net Cashflow Rs m1,760-2,800 -62.9%  

Share Holding

Indian Promoters % 43.9 54.9 79.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 20.3 4.5 453.6%  
FIIs % 15.6 4.2 372.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 56.2 45.1 124.6%  
Shareholders   237,377 161,813 146.7%  
Pledged promoter(s) holding % 0.0 74.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MARKSANS PHARMA. With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on MARKSANS PHARMA. vs Wockhardt

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

MARKSANS PHARMA. vs Wockhardt Share Price Performance

Period MARKSANS PHARMA. Wockhardt S&P BSE HEALTHCARE
1-Day 0.46% 4.99% 1.18%
1-Month -0.72% 0.15% -0.75%
1-Year 109.61% 290.07% 61.82%
3-Year CAGR 45.11% 13.79% 18.16%
5-Year CAGR 43.62% 7.92% 19.79%

* Compound Annual Growth Rate

Here are more details on the MARKSANS PHARMA. share price and the Wockhardt share price.

Moving on to shareholding structures...

The promoters of MARKSANS PHARMA. hold a 43.9% stake in the company. In case of Wockhardt the stake stands at 54.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of MARKSANS PHARMA. and the shareholding pattern of Wockhardt.

Finally, a word on dividends...

In the most recent financial year, MARKSANS PHARMA. paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 8.5%.

Wockhardt paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of MARKSANS PHARMA., and the dividend history of Wockhardt.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.